Clinical practice guidelines for anemia in chronic kidney disease: Problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Kidney International

Volumn 74, Issue 10, 2008, Pages 1237-1240

  Locatelli, Francesco ^a   Nissenson, Allen R ^b   Barrett, Brendan J ^c   Walker, Rowan G ^d   Wheeler, David C ^e   Eckardt, Kai U ^f   Lameire, Norbert H ^g   Eknoyan, Garabed ^h   Manley, Tom ⁱ  

^a A MANZONI HOSPITAL   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ NATIONAL KIDNEY FOUNDATION   (United States)

Author keywords

Anemia; Chronic kidney disease; Dialysis; Guidelines; Hemoglobin

Indexed keywords

ERYTHROPOIETIN;

ANEMIA; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON THERAPY; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANEMIA; CHRONIC DISEASE; HEMOGLOBINS; HUMANS; IRON; KIDNEY DISEASES; RENAL DIALYSIS;

EID: 55249120005     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.299     Document Type: Conference Paper

References (12)

1. National Kidney Foundation. DOQI Clinical Practice Guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30(Suppl 3): S192-S240.
2. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared to low hematocrit in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590.
3. Locatelli F, Aljama P, Bárány P et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transpl 2004; 19(Suppl 2): 1-47.
4. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47: S1-S145.
5. Locatelli F, Pisoni RL, Combe C et al. Anemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transpl 2004; 19: 121-132.
6. Parfrey PS, Foley RN, Wittreich BH et al. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 2005; 16: 2180-2189.
7. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084.
8. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098.
9. Steinbrook R. Guidance on guidelines. N Engl J Med 2007; 356: 331-332.
10. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007; 50: 471-530.
11. Pfeffer MA, for the TREAT Executive Committee. An ongoing study of anemia correction in chronic kidney disease. N Engl J Med 2007; 356: 959-961.
12. Macdougall IC, Echardt KY, Locatelli F. Latest US KDOQI anaemia guidelines update - what are the implications for Europe? Nephrol Dial Transplant 2007; 22: 2738-2742.